News
Elemental impurities analysis: anticipating our clients’ needs before they need to ask
The European Pharmacopoeia implemented the ICH Q3D guideline in June 2017, ruling the need to assess for the presence of potential elemental impurities in all drug products. Now guidelines will expand to also cover (...) Read more
Immunology: Working together to prepare for the next pandemic
Now more than ever, immunology is a hot topic as we face the numerous challenges of the COVID19 pandemic. The world is patiently awaiting new therapies and vaccines to combat this disease in hopes of (...) Read more
Nitrosamine screenings: broaden the scope today, reduce costs tomorrow
Introduction Our quality control manager and co-founder of Pharmaprogress, Dr Luca Gramaccioni has nearly two decades of experience in mass spectrometry. Here, he talks about the latest Nitrosamine deadline extension and our ahead-of-the-curve screenings. (...) Read more
Bioanalysis: Harmonization, Experience and Good Practices
The importance of ICH M10 harmonization Our head of Bioanalysis, Digna Tost has 30 years’ experience working in bioanalysis solutions. Here, she comments on the current ICH harmonization of bioanalytical global guidelines and the added (...) Read more
